Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00862186 · ClinicalTrials.gov registry record · NA
Self-Management of Cancer-Related Fatigue by Adolescents
A NA study of Neoplasms and Fatigue, sponsored by Seattle Children's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT00862186: Completed NA study of Neoplasms and Fatigue, sponsored by Seattle Children's Hospital.
NCT00862186 is a NA study of Neoplasms and Fatigue that has completed, run by Seattle Children's Hospital. The registered enrollment target is 15 participants, below the 1,621-participant average among 158 other Neoplasms trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00862186, a NA study of Neoplasms and Fatigue, has completed, sponsored by Seattle Children's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will investigate self-management of cancer-related fatigue by adolescents through pilot study of an evidence based educational resource.
Primary Outcome
The FS-A is a 14-item self-report instrument which measures on a 5 point scale ranging from '1 - not at all' to '5 - all the time' the extent to which each of 14 statements describes how the respondent has been feeling during the past 7 days (Hinds et al., 2007). The potential score range is 14-70; higher scores represent greater fatigue (Hinds et al., 2007). The scores (1 through 5) on the Likert-type scales for resource use and resource helpfulness were determined at each post baseline time po
Interventions
- BEHAVIORAL 'Fatigue Facts & Fixes'
Study Locations (1)
Washington
- Seattle Children's Hospital - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2009-04 |
| Est. Completion | 2010-12 |
| Phase | NA |
What the finished NCT00862186 record still lists
NCT00862186 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 1,621-participant average among 158 other Neoplasms trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Neoplasms appearing as the primary indexed condition, and to 1 intervention - of which 'Fatigue Facts & Fixes' is the first listed.
NCT00862186 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT00862186 about?
NCT00862186 is a clinical study titled "Self-Management of Cancer-Related Fatigue by Adolescents". This study will investigate self-management of cancer-related fatigue by adolescents through pilot study of an evidence based educational resource.
What is the current status of trial NCT00862186?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2009-04. Estimated completion is 2010-12.
What conditions does trial NCT00862186 study?
This clinical trial studies the following conditions: Neoplasms, Fatigue.
What interventions are being tested in trial NCT00862186?
The interventions under investigation include: 'Fatigue Facts & Fixes' (BEHAVIORAL).
Who is sponsoring clinical trial NCT00862186?
This trial is sponsored by Seattle Children's Hospital, which has 168 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00862186 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neoplasms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00862186's enrollment target sits among peer trials
15 150th of 158 higher than 8 of 158 other Neoplasms trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Neoplasms trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Endometrial Cell Collection With the PadKit
RECRUITING · NA
-
Serious Gaming for Chemotherapy-induced Nausea and Vomiting
RECRUITING · NA
-
Biennial CEM in Women With a Personal History of Breast Cancer
RECRUITING · NA
-
LITT Followed by Hypofractionated RT for Recurrent Gliomas
RECRUITING · NA
-
Bladder Fiducial Markers and Multiparametric-MRI (Mp-MRI) to Optimize Bladder Chemo-radiotherapy
RECRUITING · NA
-
Screening Strategies Among High-risk Populations for Anal Cancer
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia